Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of glial cells in multiple sclerosis disease progression
Luke M. Healy, Jo Anne Stratton, Tanja Kuhlmann, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 4, pp. 237-248
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Marc Charabati, Michael A. Wheeler, Howard L. Weiner, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1309-1327
Open Access | Times Cited: 119
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Interferon γ: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration
Oliver Kann, Fadi Almouhanna, Bruno Chausse
Trends in Neurosciences (2022) Vol. 45, Iss. 12, pp. 913-927
Closed Access | Times Cited: 72
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Félix Distéfano‐Gagné, Sara Bitarafan, Steve Lacroix, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 7, pp. 397-415
Closed Access | Times Cited: 54
The neuropathobiology of multiple sclerosis
Marcel S. Woo, Jan Broder Engler, Manuel A. Friese
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 7, pp. 493-513
Closed Access | Times Cited: 32
STING orchestrates the neuronal inflammatory stress response in multiple sclerosis
Marcel S. Woo, Christina Mayer, Lars Binkle-Ladisch, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 4043-4060.e30
Open Access | Times Cited: 27
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 63
Roles of Ependymal Cells in the Physiology and Pathology of the Central Nervous System
Shiyu Deng, Lin Gan, Chang Liu, et al.
Aging and Disease (2022)
Open Access | Times Cited: 43
Motor Behavioral Deficits in the Cuprizone Model: Validity of the Rotarod Test Paradigm
Concordia Lubrich, Paula Giesler, Markus Kipp
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11342-11342
Open Access | Times Cited: 42
Emerging imaging and liquid biomarkers in multiple sclerosis
Alexander J. Gill, Emily Schorr, Sachin P. Gadani, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 24
Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
Peibin Zou, Chongyun Wu, Timon Cheng‐Yi Liu, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy
Tetsuya Akaishi, Juichi Fujimori, Ichiro Nakashima
Multiple Sclerosis and Related Disorders (2024) Vol. 82, pp. 105424-105424
Closed Access | Times Cited: 15
The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology
Mathias Linnerbauer, Lena Lößlein, Oliver Vandrey, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 432-447
Open Access | Times Cited: 10
Comparative CNS Pharmacology of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis
Timothy J. Turner, Pricilla Brun, Ross C. Gruber, et al.
Drugs in R&D (2024) Vol. 24, Iss. 2, pp. 263-274
Open Access | Times Cited: 10
THE ASSOCIATION BETWEEN WHITE MATTER CHRONIC INFLAMMATION AND DEGENERATION IN MULTIPLE SCLEROSIS: A COMBINED 11C-PBR28 PET-MRI STUDY
Silvia Tommasin, Costanza Giannì, Constantina A. Treaba, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106350-106350
Closed Access | Times Cited: 1
From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions
Hadar Kolb, Omar Al‐Louzi, Erin Beck, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103194-103194
Open Access | Times Cited: 28
Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102026-102026
Open Access | Times Cited: 18
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis
Styliani Theophanous, Irene Sargiannidou, Kleopas A. Kleopa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9588-9588
Open Access | Times Cited: 7
Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders
Hongxiang Hong, Lu Xu, Qun Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Stefano De Martini, Alessandra Gemma, Marco Ferrari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3125-3125
Open Access | Times Cited: 16
Lactate as a supplemental fuel for synaptic transmission and neuronal network oscillations: Potentials and limitations
Oliver Kann
Journal of Neurochemistry (2023) Vol. 168, Iss. 5, pp. 608-631
Open Access | Times Cited: 16
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
Ahmed Abdelhak, Kai Antweiler, Markus C. Kowarik, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 11, Iss. 2, pp. 477-485
Open Access | Times Cited: 16
Synapse Dysfunctions in Multiple Sclerosis
Karin Schwarz, Frank Schmitz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1639-1639
Open Access | Times Cited: 15
Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression
Ziyan Shi, Xiaofei Wang, Jiancheng Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top